|
Volumn 3, Issue 7, 2011, Pages 686-692
|
Challenge of studies on the development of new Zn complexes (Zn(opt) 2) to treat diabetes mellitus
|
Author keywords
[No Author keywords available]
|
Indexed keywords
COORDINATION MODES;
DIABETES MELLITUS;
ORAL ADMINISTRATION;
PIOGLITAZONE;
QUALITY OF LIFE;
SIDE EFFECT;
ZN COMPLEX;
COORDINATION REACTIONS;
INSULIN;
METAL COMPLEXES;
TRANSITION METAL COMPOUNDS;
ZINC;
1 OXY 2 PYRIDINETHIOL;
ADIPONECTIN;
ANTIDIABETIC AGENT;
DI (1 OXY 2 PYRIDINETHIOLATO) ZINC;
INSULIN;
PIOGLITAZONE;
PYRIDINE DERIVATIVE;
SULFUR DERIVATIVE;
THIOL DERIVATIVE;
UNCLASSIFIED DRUG;
ZINC CHLORIDE;
ZINC SULFATE;
ZINC(DISULFURDIOXIDE);
ANIMAL EXPERIMENT;
ANIMAL MODEL;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG SYNTHESIS;
GASTROINTESTINAL ABSORPTION;
MALE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
THERAPY EFFECT;
ADIPOCYTES;
ADMINISTRATION, ORAL;
ANIMALS;
ANTIOXIDANTS;
AREA UNDER CURVE;
BLOOD GLUCOSE;
DIABETES MELLITUS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
GASTROINTESTINAL TRACT;
HYPERGLYCEMIA;
INHIBITORY CONCENTRATION 50;
INSULIN;
INSULIN RESISTANCE;
MALE;
MICE;
ORGANOMETALLIC COMPOUNDS;
PHYSICOCHEMICAL PHENOMENA;
RATS;
RATS, WISTAR;
ZINC;
|
EID: 79960197232
PISSN: 17565901
EISSN: 1756591X
Source Type: Journal
DOI: 10.1039/c1mt00014d Document Type: Conference Paper |
Times cited : (29)
|
References (44)
|